Intravenous immunoglobulins, pregnancy and multiple sclerosis

Journal of Neurology

Volumn 251, Issue 9, 2004, Pages 1138-1139

  Confavreux, Christian ^a,b  

^a INSERM   (France)

^b Service de Neurologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOMODULATING AGENT;

AUTOIMMUNE DISEASE; CHILDBIRTH; CLINICAL RESEARCH; DOSE TIME EFFECT RELATION; FATIGUE; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NOTE; POSTOPERATIVE PERIOD; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RELAPSE; RELAPSING REMITTING MULTIPLE SCLEROSIS; TERATOGENICITY;

FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREGNANCY; PREGNANCY COMPLICATIONS; RECURRENCE;

EID: 4644333910     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0496-y     Document Type: Note

References (4)

1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T and the Pregnancy in Multiple Sclerosis Group (1998) Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 339:285-291
2. Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoli B, for the Austrian Immunoglobulin in Multiple Sclerosis Group (1997) Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet 349:589-593
3. Hommes OR, Sorensen PS, Fazekas F, Maas Enriquez M, Koelmel HW, Fernandez O, Pozzilli C, O'Connor P for the ESIMS trialists, A randomised, placebo-controlled trial of intravenous immunoglobulin in secondary progressive multiple sclerosis: the European study on Immunoglobulin in MS (ESIMS). Lancet (accepted for publication)
4. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R (2004) Effect of intravenous immunoglobulin treatment on pregnancy and post-partum-related relapses in multiple sclerosis. J Neurol 251:1133-1137